3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Triple Negative Breast Neoplasms
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Waldenstrom Macroglobulinemia
1
Toxoplasmosis
1
Thrombocytosis
1
Recurrence
1
Rectal Neoplasms
1
Radiation Injuries
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Carboplatin
31
Pemetrexed
28
Radiotherapy
22
Bevacizumab
21
Cisplatin
20
Gemcitabine
18
Paclitaxel
17
Erlotinib Hydrochloride
15
Docetaxel
12
Gefitinib
8
Nivolumab
6
Mastectomy, Segmental
6
Magnetic Resonance Spectroscopy
6
pembrolizumab
5
aflutinib
5
Radiosurgery
5
tislelizumab
4
Vinorelbine
4
Surgical Procedures, Operative
4
Specimen Handling
4
Sorafenib
4
Platinum
4
Metformin
4
Biopsy
4
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
4
sargramostim
3
apatinib
3
Taxes
3
Cetuximab
3
Anterior Temporal Lobectomy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma of Lung
×
Base Sequence
×
Clear all
NCT02843711
2016-07-26
LUNG-EST
Hospices Civils de Lyon
Unknown
152 enrolled